메뉴 건너뛰기




Volumn 17, Issue SUPPL. 3, 2011, Pages

Next level of Immunosuppression: Drug/Immune monitoring

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN B; CYCLOSPORIN G; GLUCURONIDE; HYPERICUM PERFORATUM EXTRACT; IMMUNOSUPPRESSIVE AGENT; MACROLIDE; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS;

EID: 84857144782     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22385     Document Type: Article
Times cited : (22)

References (37)
  • 2
    • 79952411376 scopus 로고    scopus 로고
    • Operational tolerance: Past lessons and future prospects
    • Levitsky J. Operational tolerance: past lessons and future prospects. Liver Transpl 2011;17: 222-232.
    • (2011) Liver Transpl , vol.17 , pp. 222-232
    • Levitsky, J.1
  • 3
    • 0028204924 scopus 로고
    • Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes
    • Nagase K, Iwasaki K, Nozaki K, Noda K. Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes. J Pharm Pharmacol 1994;46: 113-117.
    • (1994) J Pharm Pharmacol , vol.46 , pp. 113-117
    • Nagase, K.1    Iwasaki, K.2    Nozaki, K.3    Noda, K.4
  • 4
    • 59349085543 scopus 로고    scopus 로고
    • Development and validation of HPLC method for the determination of cyclosporin A and its impurities in Neoral capsules and its generic versions
    • Bonifacio FN, Giocanti M, Reynier JP, Lacarelle B, Nicolay A. Development and validation of HPLC method for the determination of cyclosporin A and its impurities in Neoral capsules and its generic versions. J Pharm Biomed Anal 2009;49: 540-546.
    • (2009) J Pharm Biomed Anal , vol.49 , pp. 540-546
    • Bonifacio, F.N.1    Giocanti, M.2    Reynier, J.P.3    Lacarelle, B.4    Nicolay, A.5
  • 5
    • 0031786415 scopus 로고    scopus 로고
    • Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a highperformance liquid chromatography assay
    • Beal JL, Jones CE, Taylor PJ, Tett SE. Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a highperformance liquid chromatography assay. Ther Drug Monit 1998;20: 685-690.
    • (1998) Ther Drug Monit , vol.20 , pp. 685-690
    • Beal, J.L.1    Jones, C.E.2    Taylor, P.J.3    Tett, S.E.4
  • 6
    • 0038442626 scopus 로고    scopus 로고
    • Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients
    • Mandla R, Line PD, Midtvedt K, Bergan S. Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients. Ther Drug Monit 2003;25: 407-414.
    • (2003) Ther Drug Monit , vol.25 , pp. 407-414
    • Mandla, R.1    Line, P.D.2    Midtvedt, K.3    Bergan, S.4
  • 7
    • 23744467925 scopus 로고    scopus 로고
    • Sirolimus: The evidence for clinical pharmacokinetic monitoring
    • Stenton SB, Partovi N, Ensom MH. Sirolimus: the evidence for clinical pharmacokinetic monitoring. Clin Pharmacokinet 2005;44: 769-786.
    • (2005) Clin Pharmacokinet , vol.44 , pp. 769-786
    • Stenton, S.B.1    Partovi, N.2    Ensom, M.H.3
  • 8
    • 26444567404 scopus 로고    scopus 로고
    • The role of therapeutic monitoring of everolimus in solid organ transplantation
    • Mabasa VH, Ensom MH. The role of therapeutic monitoring of everolimus in solid organ transplantation. Ther Drug Monit 2005;27: 666-676.
    • (2005) Ther Drug Monit , vol.27 , pp. 666-676
    • Mabasa, V.H.1    Ensom, M.H.2
  • 9
    • 0141768209 scopus 로고    scopus 로고
    • Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion
    • Thervet E, Pfeffer P, Scolari MP, Toselli L, Pallardó LM, Chadban S, et al. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion. Transplantation 2003;76: 903-908.
    • (2003) Transplantation , vol.76 , pp. 903-908
    • Thervet, E.1    Pfeffer, P.2    Scolari, M.P.3    Toselli, L.4    Pallardó, L.M.5    Chadban, S.6
  • 10
    • 30444451903 scopus 로고    scopus 로고
    • Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation
    • Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, et al. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation. Liver Transpl 2005;11: 1395-1402.
    • (2005) Liver Transpl , vol.11 , pp. 1395-1402
    • Tanaka, K.1    Lake, J.2    Villamil, F.3    Levy, G.4    Marotta, P.5    Mies, S.6
  • 11
    • 33750112891 scopus 로고    scopus 로고
    • 12-month follow-up analysis of a multicenter randomized prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus
    • Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, et al. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Liver Transpl 2006;12: 1464-1472.
    • (2006) Liver Transpl , vol.12 , pp. 1464-1472
    • Levy, G.1    Grazi, G.L.2    Sanjuan, F.3    Wu, Y.4    Mühlbacher, F.5    Samuel, D.6
  • 12
    • 67649649426 scopus 로고    scopus 로고
    • Mycophenolate blood level monitoring: Recent progress
    • van Gelder T. Mycophenolate blood level monitoring: recent progress. Am J Transplant 2009;9: 1495-1499.
    • (2009) Am J Transplant , vol.9 , pp. 1495-1499
    • Van Gelder, T.1
  • 13
    • 34250159809 scopus 로고    scopus 로고
    • Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients
    • Heller T, van Gelder T, Budde K, de Fijter JW, Kuypers D, Arns W, et al. Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients. Am J Transplant 2007;7: 1822-1831.
    • (2007) Am J Transplant , vol.7 , pp. 1822-1831
    • Heller, T.1    Van Gelder, T.2    Budde, K.3    De Fijter, J.W.4    Kuypers, D.5    Arns, W.6
  • 16
    • 24044443235 scopus 로고    scopus 로고
    • Pharmacokinetic considerations relating to tacrolimus dosing in the elderly
    • Staatz CE, Tett SE. Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs Aging 2005;22: 541-557.
    • (2005) Drugs Aging , vol.22 , pp. 541-557
    • Staatz, C.E.1    Tett, S.E.2
  • 17
    • 48949099902 scopus 로고    scopus 로고
    • Measuring humanized antibodies in plasma of patients treated with antibody-based therapy using bead-based flow cytometry: The story of alemtuzumab
    • Chan HE, Jilani I, Chang R, Albitar M. Measuring humanized antibodies in plasma of patients treated with antibody-based therapy using bead-based flow cytometry: the story of alemtuzumab. Methods Mol Biol 2007; 378: 159-165.
    • (2007) Methods Mol Biol , vol.378 , pp. 159-165
    • Chan, H.E.1    Jilani, I.2    Chang, R.3    Albitar, M.4
  • 18
    • 42949146688 scopus 로고    scopus 로고
    • Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients: Preliminary report in Chile
    • Müller H, Solari S, Zuñiga C, Pedreros C, Troncoso J, Morente C, et al. Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients: preliminary report in Chile. Transplant Proc 2008;40: 705-707.
    • (2008) Transplant Proc , vol.40 , pp. 705-707
    • Müller, H.1    Solari, S.2    Zuñiga, C.3    Pedreros, C.4    Troncoso, J.5    Morente, C.6
  • 19
    • 51249111984 scopus 로고    scopus 로고
    • Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on Sandimmun Neoral
    • Al Wakeel JS, Shaheen FA, Mathew MC, Abou Zeinab HM, Al Alfi A, Tarif NM, et al. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on Sandimmun Neoral. Transplant Proc 2008;40: 2245-2251.
    • (2008) Transplant Proc , vol.40 , pp. 2245-2251
    • Al Wakeel, J.S.1    Shaheen, F.A.2    Mathew, M.C.3    Abou Zeinab, H.M.4    Al Alfi, A.5    Tarif, N.M.6
  • 20
    • 33745077432 scopus 로고    scopus 로고
    • The clinical impact of 1: 1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function
    • Qazi YA, Forrest A, Tornatore K, Venuto RC. The clinical impact of 1: 1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function. Clin Transplant 2006;20: 313-317.
    • (2006) Clin Transplant , vol.20 , pp. 313-317
    • Qazi, Y.A.1    Forrest, A.2    Tornatore, K.3    Venuto, R.C.4
  • 22
    • 34147142273 scopus 로고    scopus 로고
    • Converting to a generic formulation of mycophenolate mofetil in stable kidney transplant recipients: 1 year of drug surveillance and outcome
    • Videla C, Godoy C. Converting to a generic formulation of mycophenolate mofetil in stable kidney transplant recipients: 1 year of drug surveillance and outcome. Transplant Proc 2007;39: 602-605.
    • (2007) Transplant Proc , vol.39 , pp. 602-605
    • Videla, C.1    Godoy, C.2
  • 23
  • 24
    • 0037131879 scopus 로고    scopus 로고
    • Genetic contribution to variable human CYP3A-mediated metabolism
    • Lamba JK, Lin YS, Schuetz EG, Thummel KE. Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev 2002;54: 1271-1294.
    • (2002) Adv Drug Deliv Rev , vol.54 , pp. 1271-1294
    • Lamba, J.K.1    Lin, Y.S.2    Schuetz, E.G.3    Thummel, K.E.4
  • 25
    • 2942588886 scopus 로고    scopus 로고
    • The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation
    • MacPhee IA, Fredericks S, Tai T, Syrris P, Carter ND, Johnston A, et al. The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation. Am J Transplant 2004;4: 914-919.
    • (2004) Am J Transplant , vol.4 , pp. 914-919
    • MacPhee, I.A.1    Fredericks, S.2    Tai, T.3    Syrris, P.4    Carter, N.D.5    Johnston, A.6
  • 27
    • 69949154760 scopus 로고    scopus 로고
    • Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant
    • Hawwa AF, McKiernan PJ, Shields M, Millership JS, Collier PS, McElnay JC. Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant. Br J Clin Pharmacol 2009;68: 413-421.
    • (2009) Br J Clin Pharmacol , vol.68 , pp. 413-421
    • Hawwa, A.F.1    McKiernan, P.J.2    Shields, M.3    Millership, J.S.4    Collier, P.S.5    McElnay, J.C.6
  • 28
    • 79953167881 scopus 로고    scopus 로고
    • Immunomonitoring of nuclear factor of activated T cells-regulated gene expression: The first clinical trial in liver allograft recipients
    • Zahn A, Schott N, Hinz U, Stremmel W, Schmidt J, Ganten T, et al. Immunomonitoring of nuclear factor of activated T cells-regulated gene expression: the first clinical trial in liver allograft recipients. Liver Transpl 2011; 17: 466-473.
    • (2011) Liver Transpl , vol.17 , pp. 466-473
    • Zahn, A.1    Schott, N.2    Hinz, U.3    Stremmel, W.4    Schmidt, J.5    Ganten, T.6
  • 29
    • 33748690103 scopus 로고    scopus 로고
    • Assessing relative risks of infection and rejection: A meta-analysis using an immune function assay
    • Kowalski RJ, Post DR, Mannon RB, Sebastian A, Wright HI, Sigle G, et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 2006;82: 663-668.
    • (2006) Transplantation , vol.82 , pp. 663-668
    • Kowalski, R.J.1    Post, D.R.2    Mannon, R.B.3    Sebastian, A.4    Wright, H.I.5    Sigle, G.6
  • 30
    • 77949414863 scopus 로고    scopus 로고
    • Immune cell functional assay in monitoring of adult liver transplantation recipients with infection
    • Xue F, Zhang J, Han L, Li Q, Xu N, Zhou T, et al. Immune cell functional assay in monitoring of adult liver transplantation recipients with infection. Transplantation 2010;89: 620-626.
    • (2010) Transplantation , vol.89 , pp. 620-626
    • Xue, F.1    Zhang, J.2    Han, L.3    Li, Q.4    Xu, N.5    Zhou, T.6
  • 31
    • 67649172198 scopus 로고    scopus 로고
    • Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients
    • Cabrera R, Ararat M, Soldevila-Pico C, Dixon L, Pan JJ, Firpi R, et al. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Liver Transpl 2009;15: 216-222.
    • (2009) Liver Transpl , vol.15 , pp. 216-222
    • Cabrera, R.1    Ararat, M.2    Soldevila-Pico, C.3    Dixon, L.4    Pan, J.J.5    Firpi, R.6
  • 32
    • 51549116306 scopus 로고    scopus 로고
    • Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: Insight into the interplay between hepatitis C virus infection and cellular immunity
    • Mendler M, Kwok H, Franco E, Baron P, Weissman J, Ojogho O. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity. Liver Transpl 2008;14: 1313-1322.
    • (2008) Liver Transpl , vol.14 , pp. 1313-1322
    • Mendler, M.1    Kwok, H.2    Franco, E.3    Baron, P.4    Weissman, J.5    Ojogho, O.6
  • 33
    • 75449084723 scopus 로고    scopus 로고
    • Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression
    • Alkhouri N, Hanouneh IA, Lopez R, Zein NN. Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression. Liver Transpl 2010;16: 155-162.
    • (2010) Liver Transpl , vol.16 , pp. 155-162
    • Alkhouri, N.1    Hanouneh, I.A.2    Lopez, R.3    Zein, N.N.4
  • 35
    • 58149330244 scopus 로고    scopus 로고
    • FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal
    • Pons JA, Revilla-Nuin B, Baroja-Mazo A, Ramírez P, Martínez-Alarcón L, Sánchez-Bueno F, et al. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Transplantation 2008;86: 1370-1378.
    • (2008) Transplantation , vol.86 , pp. 1370-1378
    • Pons, J.A.1    Revilla-Nuin, B.2    Baroja-Mazo, A.3    Ramírez, P.4    Martínez-Alarcón, L.5    Sánchez-Bueno, F.6
  • 36
    • 48749084927 scopus 로고    scopus 로고
    • Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients
    • Martínez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, Lerut J, et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008;118: 2845-2857.
    • (2008) J Clin Invest , vol.118 , pp. 2845-2857
    • Martínez-Llordella, M.1    Lozano, J.J.2    Puig-Pey, I.3    Orlando, G.4    Tisone, G.5    Lerut, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.